Oncimmune Holdings plc

Oncimmune Holdings plcverified

ONC.L

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.

Industry

Biotechnology

IPO Date

2016-05-18

Stock Exchange

LSE

Ticker

ONC.L

The Enterprise Value as of November 2025 (TTM) for Oncimmune Holdings plc (ONC.L) is 5.55M

According to Oncimmune Holdings plc’s latest financial reports and current stock price. The company's current Enterprise Value is 5.55M. This represents a change of -75.64% compared to the average of 22.78M of the last 4 quarters.

Oncimmune Holdings plc (ONC.L) Historical Enterprise Value (quarterly & annually)

How has ONC.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Oncimmune Holdings plc over the last ten years is 60.00M. The current 5.55M Enterprise Value has changed 825.04% with respect to the historical average. Over the past ten years (40 quarters), ONC.L's Enterprise Value was at its highest in in the May 2021 quarter at 136.35M. The Enterprise Value was at its lowest in in the November 2018 quarter at -9046000.00.

Quarterly (TTM)
Annual

Average

60.00M

Median

62.35M

Minimum

17.29M

Maximum

133.53M

Oncimmune Holdings plc (ONC.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oncimmune Holdings plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 79.72%

Maximum Annual Enterprise Value = 133.53M

Minimum Annual Increase = -73.39%

Minimum Annual Enterprise Value = 17.29M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202417.29M-8.60%
202318.91M-73.39%
202271.09M-46.76%
2021133.53M79.72%
202074.30M43.46%
201951.79M-9.66%
201857.33M-14.91%
201767.37M79.66%
201637.50M-47.10%
201570.88M2.23%

Oncimmune Holdings plc (ONC.L) Average Enterprise Value

How has ONC.L Enterprise Value performed in the past?

The current Enterprise Value of Oncimmune Holdings plc (ONC.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

35.76M

5-year avg

63.02M

10-year avg

60.00M

Oncimmune Holdings plc (ONC.L) Enterprise Value vs. Peers

How is ONC.L’s Enterprise Value compared to its peers?

Oncimmune Holdings plc’s Enterprise Value is greater than Oxford Cannabinoid Technologies Holdings Plc (-1045660.00), greater than LungLife AI, Inc. (-679729.42), greater than Ovoca Bio plc (-2480580.00), less than LungLife AI, Inc. (0), greater than Kanabo Group Plc (13.96K), greater than DeepVerge plc (1.59M), greater than ReNeuron Group plc (-5684826.72), greater than Hellenic Dynamics Plc (-4313.00), greater than Totally plc (3.81M), greater than Destiny Pharma plc (-3509485.00),

Build a custom stock screener for Oncimmune Holdings plc (ONC.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncimmune Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncimmune Holdings plc (ONC.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncimmune Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Oncimmune Holdings plc's Enterprise Value?

What is the highest Enterprise Value for Oncimmune Holdings plc (ONC.L)?

What is the 3-year average Enterprise Value for Oncimmune Holdings plc (ONC.L)?

What is the 5-year average Enterprise Value for Oncimmune Holdings plc (ONC.L)?

How does the current Enterprise Value for Oncimmune Holdings plc (ONC.L) compare to its historical average?